Evaluating a multi-vaccine respiratory immunization strategy involving SARS-CoV-2, pneumococcal, and influenza vaccines in adults: A randomized, open-label, multicenter, controlled, non-inferiority Phase IV trial in China.
Shi X, Han S, Wu C, Wang X, Huang J, Chen W, Liu X, Wei S, Liu J, Guo X, Wang C, Wang S, Zhang M, Guo X, Zhao W, Chen H, Li Q
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.